JP2023518208A5 - - Google Patents
Info
- Publication number
- JP2023518208A5 JP2023518208A5 JP2022555078A JP2022555078A JP2023518208A5 JP 2023518208 A5 JP2023518208 A5 JP 2023518208A5 JP 2022555078 A JP2022555078 A JP 2022555078A JP 2022555078 A JP2022555078 A JP 2022555078A JP 2023518208 A5 JP2023518208 A5 JP 2023518208A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- therapeutic agent
- amino
- agent according
- haloalkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010177429.3 | 2020-03-13 | ||
| CN202010177429 | 2020-03-13 | ||
| PCT/CN2021/080540 WO2021180219A1 (zh) | 2020-03-13 | 2021-03-12 | Pi4k抑制剂的抗冠状病毒效果以及应用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023518208A JP2023518208A (ja) | 2023-04-28 |
| JP2023518208A5 true JP2023518208A5 (cg-RX-API-DMAC10.html) | 2024-03-21 |
Family
ID=77672132
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022555078A Pending JP2023518208A (ja) | 2020-03-13 | 2021-03-12 | Pi4k阻害物質の抗コロナウイルス効果および応用 |
Country Status (10)
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2024004055A (es) * | 2021-09-30 | 2024-06-19 | Nuo Beta Pharmaceutical Tech Shanghai Co Ltd | Compuesto de oxido de fenilarsina halogenado y aplicacion del mismo. |
| CN117695281B (zh) * | 2023-12-26 | 2024-06-21 | 广州医科大学 | 四氢喹啉酮-酰胺-噻唑类化合物的应用 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4923895A (en) * | 1988-10-24 | 1990-05-08 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Method of treatment of human immunodeficiency virus |
| US5532154A (en) * | 1994-03-21 | 1996-07-02 | Research Development Foundation | Mutated alpha virus |
| EP0981344A1 (en) * | 1997-05-14 | 2000-03-01 | The University of New Mexico | Inhibition of cell surface protein disulfide isomerase |
| AU2149600A (en) * | 1998-11-12 | 2000-05-29 | Musc Foundation For Research Development | Methods and compositions for treating common cold symptoms |
| CN1914226B (zh) * | 2003-11-25 | 2012-02-01 | 达纳-法伯癌症研究院有限公司 | SARS-CoV抗体及其使用方法 |
| US7592322B2 (en) * | 2004-10-22 | 2009-09-22 | Alnylam Pharmaceuticals, Inc. | RNAi modulation of RSV, PIV and other respiratory viruses and uses thereof |
| WO2009121219A1 (zh) * | 2008-04-02 | 2009-10-08 | Ding Xinkan | 砷化物在制备抗病毒药物中的应用 |
| WO2012174312A2 (en) * | 2011-06-15 | 2012-12-20 | Glaxosmithkline Llc | Benzimidazole derivatives as antiviral agents |
| WO2015135652A1 (en) * | 2014-03-12 | 2015-09-17 | Technische Universität München | Antagonists of acid lipase for preventing virus infection |
| WO2016172952A1 (zh) * | 2015-04-30 | 2016-11-03 | 江苏挪贝肽医药科技有限公司 | PI4KIIIα蛋白及相关的膜蛋白复合体在治疗阿尔茨海默病中的应用 |
| ES3010661T3 (en) * | 2016-02-26 | 2025-04-04 | Univ Leland Stanford Junior | Pi-kinase inhibitors with anti-infective activity |
| CN108721622B (zh) * | 2017-04-14 | 2022-10-25 | 中国科学院上海高等研究院 | 抑制肝纤维化的试剂及应用 |
| EP4130014A4 (en) * | 2020-03-31 | 2024-05-15 | Nuo-Beta Pharmaceutical Technology (Shanghai) Co., Ltd. | Deuterated oxophenylarsine compound and use thereof |
-
2021
- 2021-03-12 AU AU2021236089A patent/AU2021236089B2/en not_active Ceased
- 2021-03-12 CN CN202180026954.8A patent/CN115884789B/zh active Active
- 2021-03-12 JP JP2022555078A patent/JP2023518208A/ja active Pending
- 2021-03-12 CA CA3170611A patent/CA3170611A1/en active Pending
- 2021-03-12 KR KR1020227033463A patent/KR20230022150A/ko not_active Ceased
- 2021-03-12 WO PCT/CN2021/080540 patent/WO2021180219A1/zh not_active Ceased
- 2021-03-12 US US17/911,103 patent/US20250152599A1/en active Pending
- 2021-03-12 EP EP21768762.3A patent/EP4119164A4/en not_active Withdrawn
- 2021-03-12 MX MX2022011138A patent/MX2022011138A/es unknown
-
2022
- 2022-09-12 ZA ZA2022/10111A patent/ZA202210111B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN107693797B (zh) | 肽寡核苷酸缀合物 | |
| JP6294889B2 (ja) | ウイルス疾患の処置におけるmek阻害物質 | |
| TW201623265A (zh) | 抗病毒化合物、醫藥組合物及其使用方法 | |
| TW201542538A (zh) | 抗病毒化合物、醫藥組合物及其使用方法 | |
| JP2010501584A5 (cg-RX-API-DMAC10.html) | ||
| JP2014526456A (ja) | 過剰増殖性疾患、好ましくはp53機能欠損の治療に用いるためのCIP2Aサイレンシング剤を含む併用薬剤 | |
| JP2014505107A5 (cg-RX-API-DMAC10.html) | ||
| TW201907009A (zh) | 用於治療b型肝炎之治療組成物及方法 | |
| JP2024530956A5 (cg-RX-API-DMAC10.html) | ||
| TW201625573A (zh) | 色烯酮(chromenone)抗病毒化合物、醫藥組合物及其使用方法 | |
| BR112020018601A2 (pt) | Regime de dosagem de modulador de montagem de capsídeo | |
| WO2019046287A1 (en) | COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING HEPATITIS B | |
| CN115884789A (zh) | Pi4k抑制剂的抗冠状病毒效果以及应用 | |
| JP2022529061A5 (cg-RX-API-DMAC10.html) | ||
| CA2738070C (en) | Novel compounds for the treatment or alleviation of edema, and methods for their use | |
| CN118401665A (zh) | 具有高稳定性和基因沉默活性的小干扰rna分子的修饰模式 | |
| CN114729360A (zh) | 降低病毒分子水平的方法 | |
| US10358447B2 (en) | Substituted 2-N-hydroxy-1,3-dioxo-1,2,3,4-tetrahydronaphthyridines, and methods of making and using same | |
| US20240216365A1 (en) | Methods and uses of protein disulfide isomerase inhibitory compounds | |
| JP7590351B2 (ja) | Prmt5阻害剤を使用した癌の治療法 | |
| JP2022550072A5 (cg-RX-API-DMAC10.html) | ||
| CN114057816B (zh) | 富含腺嘌呤硫代磷酸酯化寡核苷酸及其抗肝炎病毒的应用 | |
| JP2021529189A5 (cg-RX-API-DMAC10.html) | ||
| US20230364074A1 (en) | Compounds and Compositions for Disrupting Programmed Ribosomal Frameshifting | |
| JP2015527316A5 (cg-RX-API-DMAC10.html) |